PUBLIC COMPANY LIMITED (“the Company”) would like to provide an explanation regarding our financial performance and position for the 3-month period ended 31 March 2019 as follows: Financial Performance For
President The Stock Exchange of Thailand 1. Overview financial performance of E for L Aim Public Company Limited (“EFORL” or “the Company”) and its subsidiaries (collectively as “the Companies”) for Q1/2019
Printing Public Company Limited (the "Company") No. 13/2018 held on December 12, 2018 has approved the Company to purchase shares of the WPS (Thailand) Co., Ltd. (“WPS”), which is a company that is in
: President The Stock Exchange of Thailand Pursuant to JAS Asset Public Company Limited (“the Company”) Meeting Resolution No. 6/2019 on 6 August 2019, the resolution to certify the Company’s financial
performance of E for L Aim Public Company Limited (“EFORL” or “the Company”) and its subsidiaries (collectively as “the Companies”) for Q2/2019 Financial performances Comparison is as follows: THB’000 Q2/2019
. Property Public Company Limited and its subsidiaries (“company and subsidiaries) would like to clarify our operating results for the year ended December 31, 2017 as follows:- (Unit: million Baht) For 12
performance of E for L Aim Public Company Limited (“EFORL” or “the Company”) and its subsidiaries (collectively as “the Companies”) for Q1/2018 Financial performances Comparison is as follows: THB’000
/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
โรงพยาบาลราชพฤกษ์ บริษัท โรงพยาบาลราชพฤกษ์ จ ากัด (มหาชน) Ratchaphruek Hospital Public Company Limited 150/18 ถนนมิตรภาพ ต าบลในเมือง อ าเภอเมือง จังหวัดขอนแก่น 40000 โทร (043) 333-555 โทรสาร (043
/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited